Barinthus Biotherapeutics (BRNS) Shareholder's Equity (2020 - 2026)

Barinthus Biotherapeutics (BRNS) Shareholder's Equity (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 7.14 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 795.79 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 595,226.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 14.38 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.37 Bn 94.37 Bn - 502.95 Mn
10 Barinthus Biotherapeutics 27.08 Mn -40.03 Mn - 66.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.40 Mn
Dec 31, 2025 74.21 Mn
Sep 30, 2025 84.56 Mn
Jun 30, 2025 102.48 Mn
Mar 31, 2025 115.59 Mn
Dec 31, 2024 130.14 Mn
Sep 30, 2024 159.46 Mn
Jun 30, 2024 156.79 Mn
Mar 31, 2024 172.02 Mn
Dec 31, 2023 187.00 Mn
Sep 30, 2023 195.60 Mn
Jun 30, 2023 217.46 Mn
Mar 31, 2023 233.57 Mn
Dec 31, 2022 243.20 Mn
Sep 30, 2022 244.15 Mn
Jun 30, 2022 254.77 Mn
Mar 31, 2022 253.14 Mn
Dec 31, 2021 252.56 Mn
Sep 30, 2021 242.47 Mn
Jun 30, 2021 249.91 Mn